Optomed PlcStock Exchange Release14 August 2026 at 9.30, Helsinki
Optomed’s financial reporting in 2027
Optomed Plc will release its Financial Statement Bulletin, Half-Year Financial Report and Interim Reports in 2027 as follows:
- Financial Statement Bulletin for 1 January – 31 December 2026, 18 February 2027
- Interim Report for 1 January – 31 March 2027, 4 May 2027
- Half-Year Financial Report for 1 January – 30 June 2027, 12 August 2027
- Interim Report for 1 January – 30 September 2027, 4 November 2027
Annual Report 2026, which includes the company’s financial statements, the report of the Board of Directors, the corporate governance statement and the remuneration report, will be published during the week starting on 1 March 2027 at the latest.
Optomed’s Annual General Meeting is planned to be held on 11 May 2027 in the Helsinki region, Finland. The Board of Directors will convene the meeting separately at a later date.
A shareholder who requests a certain issue belonging to the General Meeting to be included on the agenda of the meeting, is asked to notify the Board of Directors in writing by post Optomed Plc, Yrttipellontie 1, FI-90230 Oulu, Finland no later than 13 March 2027.
Optomed Plc
Further enquiries
Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases, such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.